Cargando…
A review of fenfluramine for the treatment of Dravet syndrome patients
INTRODUCTION: Dravet Syndrome (DS) is a rare epileptiform disorder typically presenting within the first year of life of a normally developing infant. It is characterized by several prolonged seizures that are often resistant to current anti-epileptic drug (AED) regimens. This paper outlines the his...
Autores principales: | Simon, Kayla, Sheckley, Hunter, Anderson, Christopher L., Liu, Zhao, Carney, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695265/ https://www.ncbi.nlm.nih.gov/pubmed/34988433 http://dx.doi.org/10.1016/j.crphar.2021.100078 |
Ejemplares similares
-
Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020) -
Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023) -
Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023) -
Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome
por: Millett, David, et al.
Publicado: (2021) -
Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Wijnen, Ben, et al.
Publicado: (2022)